Pricing Log in Create free account

Actuate Therapeutics, Inc. (ACTU) vs Pasithea Therapeutics Corp. (KTTA)

Actuate Therapeutics, Inc. and Pasithea Therapeutics Corp. are both Biotechnology companies. Actuate Therapeutics, Inc. and Pasithea Therapeutics Corp. are of similar size ($18.0M and $17.4M). Across the 9 metrics below, Pasithea Therapeutics Corp. leads on 6 and Actuate Therapeutics, Inc. on 3.

Valuation

Metric ACTU KTTA Biotechnology median
P/E n/m n/m 10.60
P/S n/m 38.26 9.40
P/B 7.72 0.37 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 1.17 0.66
EV/Sales n/m (55.79) 9.02
Earnings yield (271.88%) (254.86%) (32.88%)
Free cash flow yield (259.67%) (94.76%) (23.13%)

Profitability

Metric ACTU KTTA Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 2,457.65% (65.49%) (51.96%)
Return on assets (336.18%) (61.97%) (46.06%)
Return on invested capital 0.00% (367.46%) 0.00%

Growth

Metric ACTU KTTA Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 67.48% 77.07% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ACTU KTTA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.25 26.25 4.97
Net debt to EBITDA 0.59 2.74 1.01

Dividend

Metric ACTU KTTA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ACTU KTTA Biotechnology median
Market cap 17.98m 17.38m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack